TrialClinical pharmacology in drug development2023

First-in-Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15-Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis.

Lan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.